Cordis ExoSeal™ Vascular Closure Device - HSA Registration DE0006442
Access comprehensive regulatory information for Cordis ExoSeal™ Vascular Closure Device in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0006442 and owned by Cordis US Corp.. The device was registered on March 31, 2011.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The ExoSeal™ Vascular Closure Device is indicated for femoral artery puncture site closure, reducing time to hemostasis and ambulation in patients who have undergone diagnostic or interventional procedures using a standard corresponding French size vascular sheath introducer with up to a 12 cm working length. Additionally, the ExoSeal™ Vascular Closure Device is indicated to reduce times to hemostasis and ambulation in patients who have undergone interventional catheterization procedures, using a standard 6F vascular sheath introducer up to a 12 cm working length, who have received preprocedural and/or intraprocedural glycoprotein (GP) IIb/IIIa inhibitor therapy.